Low-molecular-weight heparin compared with unfractionated heparin in critically ill COVID-19 patients

被引:4
|
作者
Volteas, Panagiotis [1 ]
Drakos, Panagiotis [1 ]
Alkadaa, Leor N. [2 ]
Cleri, Nathaniel A. [2 ]
Asencio, Anthony A. [2 ]
Oganov, Anthony [2 ]
Giannopoulos, Stefanos [1 ,3 ]
Saadon, Jordan R. [2 ]
Mikell, Charles B., III [2 ]
Rubano, Jerry A. [1 ]
Labropoulos, Nicos [3 ]
Tassiopoulos, Apostolos K. [1 ,3 ]
Mofakham, Sima [2 ]
Bannazadeh, Mohsen [1 ,3 ]
机构
[1] Renaissance Sch Med, Dept Surg, Stony Brook, NY USA
[2] Renaissance Sch Med, Dept Neurosurg, Stony Brook, NY USA
[3] Renaissance Sch Med, Div Vasc Surg, Dept Surg, Stony Brook, NY USA
关键词
COVID-19; SARS-CoV-2; Low-molecular-weight heparin (LMWH); Unfractionated heparin (UFH); Thromboprophylaxis; Anticoagulation (AC); ANTICOAGULATION; ENOXAPARIN;
D O I
10.1016/j.jvsv.2022.04.019
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Thrombosis in COVID-19 worsens mortality. In our study, we sought to investigate how the dose and type of anticoagulation (AC) can influence patient outcomes. Methods: This is a single-center retrospective analysis of critically ill intubated patients with COVID-19, comparing low-molecular-weight heparin (LMWH) and unfractionated heparin (UFH) at therapeutic and prophylactic doses. Of 218 patients, 135 received LMWH (70 prophylactic, 65 therapeutic) and 83 UFH (11 prophylactic, 72 therapeutic). The primary outcome was mortality. Secondary outcomes were thromboembolic complications confirmed on imaging and major bleeding complications. Cox proportional-hazards regression models were used to determine whether the type and dose of AC were independent predictors of survival. We performed Kaplan-Meier survival analysis to compare the cumulative survivals. Results: Overall, therapeutic AC, with either LMWH (65% vs 79%, P = .09) or UFH (32% vs 46%, P = .73), conveyed no survival benefit over prophylactic AC. UFH was associated with a higher mortality rate than LMWH (66% vs 28%, P= .001), which was also evident in the multivariable analysis (LMWH vs UFH mortality, hazard ratio: 0.47, P = .001) and in the Kaplan-Meier survival analysis. Thrombotic and bleeding complications did not depend on the AC type (prophylactic LMWH vs UFH: thrombosis P = .49, bleeding P = .075; therapeutic LMWH vs UFH: thrombosis P = .5, bleeding P = .17). When comparing prophylactic with therapeutic AC, the rate of both thrombotic and bleeding complications was higher with the use of LMWH compared with UFH. In addition, transfusion requirements were significantly higher with both therapeutic LMWH and UFH. Conclusions: Among intubated critically ill COVID-19 intensive care unit patients, therapeutic AC, with either LMWH or UFH, conveyed no survival benefit over prophylactic AC. AC with LMWH was associated with higher cumulative survival compared with AC with UFH.
引用
收藏
页码:1128 / 1136
页数:9
相关论文
共 50 条
  • [41] A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism
    Simonneau, G
    Sors, H
    Charbonnier, B
    Page, Y
    Laaban, JP
    Azarian, R
    Laurent, M
    Hirsch, JL
    Ferrari, E
    Bosson, JL
    Mottier, D
    Beau, B
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (10): : 663 - 669
  • [42] Unfractionated Heparin Versus Low-Molecular-Weight Heparin for Avoiding Heparin-Induced Thrombocytopenia in Postoperative Patients
    Ang, Emily
    [J]. CLINICAL NURSE SPECIALIST, 2013, 27 (05) : 229 - 230
  • [43] Cost effectiveness of thromboprophylaxis with a low-molecular-weight heparin versus unfractionated heparin in acutely ill medical inpatients
    McGarry, LJ
    Thompson, D
    Weinstein, MC
    Goldhaber, SZ
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2004, 10 (09): : 632 - 642
  • [44] Low-molecular-weight heparin versus unfractionated heparin for unstable coronary disease
    Krulewitz, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (02): : 130 - 130
  • [45] COMPARISON OF LOW-MOLECULAR-WEIGHT HEPARIN AND UNFRACTIONATED HEPARIN IN THE TREATMENT OF DVT - A METAANALYSIS
    LEIZOROVICZ, A
    SIMONNEAU, G
    DECOUSUS, H
    [J]. THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 647 - 647
  • [46] COMPARISON OF LOW-MOLECULAR-WEIGHT HEPARIN VS UNFRACTIONATED HEPARIN IN GYNECOLOGICAL SURGERY .2. REDUCED DOSE OF LOW-MOLECULAR-WEIGHT HEPARIN
    BORSTAD, E
    URDAL, K
    HANDELAND, G
    ABILDGAARD, U
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1992, 71 (06) : 471 - 475
  • [47] Low-molecular-weight heparin reduces the cost of venous thromboembolism treatment compared with unfractionated heparin in US hospitals
    Merli, Geno J.
    Ferrufino, Cheryl P.
    Lin, Jay
    Hussein, Mohamed
    Battleman, David
    [J]. BLOOD, 2007, 110 (11) : 551A - 551A
  • [48] Low-molecular-weight heparin in acute coronary syndrome: Evidence for superior or equivalent efficacy compared to unfractionated heparin?
    Kaul, S
    Cercek, B
    Shah, PK
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 344A - 344A
  • [49] Safety of low-molecular-weight heparin compared to unfractionated heparin in hemodialysis: a systematic review and meta-analysis
    Hind Harrak Lazrak
    Émilie René
    Naoual Elftouh
    Martine Leblanc
    Jean-Philippe Lafrance
    [J]. BMC Nephrology, 18
  • [50] Safety of low-molecular-weight heparin compared to unfractionated heparin in hemodialysis: a systematic review and meta-analysis
    Lazrak, Hind Harrak
    Rene, Emilie
    Elftouh, Naoual
    Leblanc, Martine
    Lafrance, Jean-Philippe
    [J]. BMC NEPHROLOGY, 2017, 18